Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Zygomatic Implants Show Promising Results in Patients With Severe Maxillary Atrophy


News provided by

KnowledgeWorks Global

Jan 02, 2026, 16:29 ET

Share this article

Share toX

Share this article

Share toX


Researchers from the University of Zurich and collaborating institutions published a retrospective study in the Journal of Oral Implantology evaluating long-term outcomes of two zygomatic implant techniques—quad-zygoma and hybrid-zygoma—for patients with severe maxillary atrophy. Analyzing 262 implants with an average follow-up of 67.6 months, the study reported a 96.9% overall survival rate, with biological complications such as sinusitis occurring in 27.6% of patients and technical complications in 6.5% of cases. Despite complication rates, patient satisfaction was high, with 94.7% of survey respondents saying they were satisfied and would choose the procedure again, supporting zygomatic implants as a viable long-term alternative to traditional implant approaches for extensive bone loss.

GLEN ALLEN, Va., Jan. 2, 2026 /PRNewswire-PRWeb/ -- Journal of Oral Implantology – In dentistry, patients with severe maxillary atrophy present significant functional and aesthetic challenges because traditional dental implants are often insufficient due to extreme bone loss. Individuals with inadequate bone volume often have limited treatment options, leaving many unable to benefit from dental implants without extensive grafting procedures. In recent years, zygomatic implants have emerged as a promising alternative; however, the literature remains limited regarding the long-term reliability, potential complications, and patient satisfaction associated with two established zygomatic implant techniques.

Researchers from the University of Zurich in Zurich, Switzerland, the Center for Clinical Research and Evidence Synthesis in Oral Tissue Regeneration in Ann Arbor, Michigan, the Ärzte- und Zahnärztehaus Glarus Süd in Schwanden, Switzerland, and Cranio Faciales Centrum in Aarau, Switzerland recently published a retrospective study in the Journal of Oral Implantology examining patient outcomes when using zygomatic implant techniques.

"The primary objective of this study was to evaluate the survival rate of zygomatic implants following two distinct surgical approaches: (i) the quad-zygoma and (ii) hybrid-zygoma approaches. Secondary outcomes included the assessment of biological and technical complications."

Post this

Lead author Leonardo Mancini, DDS, PhD, and colleagues state, "The primary objective of this study was to evaluate the survival rate of zygomatic implants following two distinct surgical approaches: (i) the quad-zygoma and (ii) hybrid-zygoma approaches. Secondary outcomes included the assessment of biological and technical complications."

The study analyzed 262 zygomatic implants, 220 placed in the quad-zygoma group and 42 in the hybrid-zygoma group, with an average follow-up period of 67.6 months. Researchers focused on the biological complications of sinusitis and soft tissue problems, while technical issues were defined as those related to bridge fractures, loose screws, or abutment fractures.

Results showed an overall implant survival rate of 96.9%, with only eight failures. Researchers also reported biological complications in 27.6% of patients, most commonly sinusitis, and technical complications in 6.5% of cases, including screw fractures and loosening. Despite these issues, patient feedback remained overwhelmingly positive. Among the 40 patients (51.3%) who completed a satisfaction survey, the majority (94.7%) expressed high satisfaction with their outcomes and indicated they would choose to undergo the procedure again.

Overall, the study confirms that both quad- and hybrid-zygoma techniques offer promising long-term results for individuals with extensive maxillary atrophy. Mancini and colleagues conclude that "Zygomatic implants provide a viable alternative for the rehabilitation of atrophic maxillae. Although they are associated with a higher incidence of biological and mechanical complications than conventional techniques, the long-term survival rates of both implants and their corresponding prostheses remain favorable. Moreover, both the hybrid and quad zygoma approaches have demonstrated high survival rates and strong patient acceptance."

Full text of the article, "Zygomatic Implants in Severe Maxillary Atrophy: 5.5-year Retrospective Analysis of 262 Cases," Journal of Oral Implantology, Vol. 51, No. 6, 2025, is available at joionline.org.

Media Contact

Maria Preston-Cargill, KnowledgeWorks Global, 1 7852892532, [email protected], https://www.kwglobal.com/

SOURCE KnowledgeWorks Global

Modal title

Journal of Oral Implantology
Journal of Oral Implantology
Journal of Oral Implantology

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.